Tech-focused firm sees PEP grow 8.2% following almost 20% decline in 2022 | 4mos

The top 25 US firm secures highly respected team of tech-focused IP litigators in Silicon Valley and Washington DC | 4mos

Partner Robert Stroud joins from Florida firm Blalock Walters alongside counsel and an associate | 4mos

Court rules specialist IP firms lack “legal interest” in transparency test case involving Ocado and Autostore | 6mos

Team advising medtech company on dispute before USPTO helped found A&O’s West Coast practice | 7mos

IP firm believe the newly established court is interpreting the public access rules too restrictively, looks to the EPO as a ‘paragon of openness’ in this area | 7mos

Service aims to settle IP disputes in a single process avoiding the expense and complexity of litigation | 8mos

USPTO seeks to encourage “broader participation” in bar | 8mos

Data specialist Maureen Daly joins from Beauchamps as Pinsents moves to build Europe tech and science sector offering | 8mos

IP filings have “braved” the pandemic, but WIPO director general warns of geopolitical instability and an uncertain economic outlook | 8mos

Private capital push also sees Anglo-Australian firm appoint new partner from DLA Piper to co-head UK venture capital practice | 9mos

Quartet of patent experts joins recent Cooley hire Amy Baker Mandragouras to boost Foley’s life sciences IP practice | 9mos

Join brand protection managers, law enforcement and technology innovators on 18 October to share best practice in the fight against counterfeits | 9mos

Rouse beefs up its intellectual property enforcement team with two new appointments in response to client need amid the changing anti-counterfeiting landscape | 9mos

Agreement adds to CMS’s Latin America presence in Chile, Colombia, Mexico and Peru | 9mos

Hemmie Chang joins to lead new life sciences-focused office | 10mos

Forward Global’s head of illicit trade risk management on the unique challenges of combatting counterfeiters on the African continent | 10mos

Veteran litigators join amid uptick in federal and state regulatory scrutiny facing product manufacturers | 10mos

Skadden advises US medical giant Danaher as Latham acts for UK’s Abcam in all-cash deal | 10mos